Abstract:Background Cardiometabolic multimorbidity (CMM) with at least two cardiometabolic diseases (CMDs) including type II diabetes (T2D), ischemic heart disease (IHD), and stroke, is a global health problem with multiplicative mortality risk and deserves to be investigated as a top priority. Although air pollution is a leading modifiable environmental risk for individual CMD, its impacts on CMM progression were poorly understood.Objective To elucidate the impact of air pollution on CMM progression, individually and in the context of genetic preposition.Design Multi-state modeling cohort study.Setting Data were extracted from the UK Biobank.Participants 415,855 eligible UK Biobank adults that were free of CMDs at baseline.Measurements Annual concentrations of particulate matter (PM) with a diameter of ≤2.5 μm (PM2.5), 2.5-10 μm (PM2.5-10), and ≤10 μm (PM10), and nitrogen oxides (NOx and NO2) were estimated using Land Use Regression model.Results During a median follow-up of 8.93 years, 33,375 participants had a first CMD (FCMD), and 3,257 subsequently developed CMM. PM2.5, PM10, NO2, and NOx levels, as well as their combined exposure were associated with increased FCMD risks and even higher risks of CMM. Particularly, per a 5-μg/m3 increase in PM2.5, risks for FCMD and CMM increased by 27% (95% confidence interval: 20%-34%) and 41% (18%-68%), respectively. By FCMD types, participants with IHD had a higher risk of CMM than those with T2D or stroke. Eighty-five CMD-related genetic variants were associated with CMM trajectories in our study and associations of air pollution with FCMD and CMM risks could be aggravated progressively with increasing genetic risks.Limitations Other major air pollutants including ozone and SO2 were not considered due to the data availability.Conclusions Air pollution has profound adverse health impacts on the progression of CMM through multi-stage dynamics, especially for individuals with IHD and high genetic risk.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementDr. Xu Gao was supported by grants from the Peking University (BMU2021YJ044) and China CDC Key Laboratory of Environment and Population Health (2022-CKL-03).### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UK Biobank Resource under Application Number 44430. The UK Biobank data are available on application to the UK Biobank (www.ukbiobank.ac.uk/).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available in a public, open access repository. This research has been conducted using the UK Biobank Resource under Application Number 44430. The UK Biobank data are available on application to the UK Biobank (www.ukbiobank.ac.uk/).

Genome‐wide association study of cardiometabolic multimorbidity in the UK Biobank

Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study.

Observational and genetic associations of adiposity with cardiopulmonary multimorbidity: Linear and nonlinear Mendelian randomization analysis

Genetic Correlations and Causal Relationships Between Cardio-Metabolic Traits and Sepsis

Novel Common Variants Associated with Body Mass Index and Coronary Artery Disease Detected Using a Pleiotropic Cfdr Method.

A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank

Long-term Air Pollution, Cardiometabolic Multimorbidity, and Genetic Susceptibility: a Prospective Study in UK Biobank Cohort

Lifestyle and clinical factors as predictive indicators of cardiometabolic multimorbidity in Chinese adults: Baseline findings of the Beijing Health Management Cohort (BHMC) study

Causal association between 1400 metabolites and dilated cardiomyopathy: a bidirectional two-sample Mendelian randomization analysis

Long-Term Air Pollution, Cardiometabolic Multimorbidity, and Genetic Susceptibility: A Multi-State Modeling Study of 415,855 Participants

Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease

Multivariate Analysis of Genome-Wide Data to Identify Potential Pleiotropic Genes for Type 2 Diabetes, Obesity and Coronary Artery Disease Using MetaCCA

Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank

Genome-Wide and Exome-Wide Association Study Identifies Genetic Underpinning of Comorbidity between Myocardial Infarction and Severe Mental Disorders

Accelerated biological aging, cardiovascular risks, and cardiometabolic multimorbidity: a cohort study

Genome-wide insights into the shared genetic landscape between metabolic dysfunction-associated fatty liver disease and cardiovascular diseases

Parental cardiometabolic multimorbidity and subsequent cardiovascular incidence in middle-aged adults: A prospective cohort study

Causal Effect of the Triglyceride-Glucose Index and the Joint Exposure of Higher Glucose and Triglyceride With Extensive Cardio-Cerebrovascular Metabolic Outcomes in the UK Biobank: A Mendelian Randomization Study

Ultra-processed food, genetic risk, and the risk of cardiometabolic diseases and cardiometabolic multimorbidity: a prospective study

Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity

The Association Between Fatigue and Cardiometabolic Diseases: Insights from the UK Biobank Study